The use of vancomycin powder in the compound depressed skull fractures

dc.authorid0000-0003-3620-2993
dc.contributor.authorUysal, Ece
dc.contributor.authorCal, Mehmet Alpay
dc.contributor.authorCine, Hidayet Safak
dc.date.accessioned2025-05-10T19:49:04Z
dc.date.issued2023
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractBackground/aim: Compound or open depressed fractures (CDF) is one of the urgent operations of neurosurgery, as it can result in complications of infection. This study is reported to investigate the effect of topical vancomycin powder to the infection rates in the compound depressed skull fractures which have been operated on. Materials and methods: This present study was conducted on 46 cases with compound depressed skull fractures which have been operated on. Cases were divided into two groups according to the use of subgaleal topical vancomycin powder during the operation. The preoperative and postoperative CRP levels, localization of the fracture, hospitalization time, operation length, dural injury, pneumocephalus, and mortality rates have been examined.Results: In cases with dural injury and pneumocephalus, a statistically significant relationship was found between the use of topical vancomycin powder and the frequency of post-op infection (p < 0.001). It was observed that the incidence of postoperative infection was significantly higher in 12 (85.7%) cases with pneumocephalus and dural injury when vancomycin powder was not used. Also, it was observed that the post-operative infection level was significantly higher in fractures in the frontal and parietal regions without vancomycin powder(p < 0.05).Conclusions: The use of subgaleal topical vancomycin powder is an option to reduce the infection rates and mortality, especially in the cases of compound depressed fractures, which is considered as a dirty wound and prone to infection. It is especially recommended in the presence of dural injury and pneumocephalus.
dc.identifier.doi10.1016/j.clineuro.2022.107570
dc.identifier.issn0303-8467
dc.identifier.issn1872-6968
dc.identifier.pmid36587442
dc.identifier.scopus2-s2.0-85144975526
dc.identifier.scopusqualityQ2
dc.identifier.urihttps://doi.org/10.1016/j.clineuro.2022.107570
dc.identifier.urihttps://hdl.handle.net/20.500.14730/11889
dc.identifier.volume225
dc.identifier.wosWOS:000921191300001
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherElsevier
dc.relation.ispartofClinical Neurology and Neurosurgery
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250302
dc.subjectSkull fracture
dc.subjectInfection presentation
dc.subjectVancomycin
dc.subjectHead trauma
dc.subjectCraniotomy
dc.titleThe use of vancomycin powder in the compound depressed skull fractures
dc.typeArticle

Dosyalar